Authors:
LAGNEAUX L
DELFORGE L
BERNIER M
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., TGF-BETA ACTIVITY AND EXPRESSION OF ITS RECEPTORS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 31(1-2), 1998, pp. 99
Authors:
TRENSCHEL R
BERNIER M
DELFORGE A
MASSY M
DEHEMRICOURT EL
MAEREVOET M
BADJOU R
STRYCKMANS P
BRON D
Citation: R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 325-352
Authors:
BLEIBERG H
DUCHATEAU J
MBON JBN
GERARD B
BRON D
DEBUSSCHER L
STRYCKMANS P
Citation: H. Bleiberg et al., INCREASED INCIDENCE OF LYMPHOMAS AND CARCINOMAS IN PATIENTS WITH CELIAC-DISEASE, European journal of cancer, 34(4), 1998, pp. 592-593
Authors:
LOWENBERG B
SUCIU S
ARCHIMBAUD E
HAAK H
STRYCKMANS P
DECATALDO R
DEKKER AW
BERNEMAN ZN
THYSS A
VANDERLELIE J
SONNEVELD P
VISANI G
FILLET G
HAYAT M
HAGEMEIJER A
SOLBU G
ZITTOUN R
Citation: B. Lowenberg et al., MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9, Journal of clinical oncology, 16(3), 1998, pp. 872-881
Authors:
BRON D
DELFORGE A
BOSMANS E
BRUGGEMAN C
SNOECK R
DECLERCQ E
STRYCKMANS P
LAGNEAUX L
Citation: D. Bron et al., DYSREGULATION OF CYTOKINE PRODUCTION BY BONE-MARROW STROMAL CELLS AFTER EXPOSURE TO HUMAN CYTOMEGALOVIRUS (HUCMV) OR RECOMBINANT PROTEINS OF HUCMV, British Journal of Haematology, 102(1), 1998, pp. 18-19
Authors:
BRON D
MEULEMAN N
DEBRUYNE JM
MAEREVOET M
RIZOPOULO H
STRYCKMANS P
Citation: D. Bron et al., CMV INFECTION AND DISEASE IN 100 ALLOGENEIC BMT PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 208-209
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC LEUKEMIC B-CELLS BUT NOT NORMAL B-CELLS ARE RESCUED FROM APOPTOSIS BY CONTACT WITH NORMAL BONE-MARROW STROMAL CELLS, Blood, 91(7), 1998, pp. 2387-2396
Authors:
WILLEMZE R
SUCIU S
ARCHIMBAUD E
MUUS P
STRYCKMANS P
LOUWAGIE EA
BERNEMAN Z
TJEAN M
WIJERMANS P
DOHNER H
JEHN U
LABAR B
JAKSIC B
DARDENNE M
ZITTOUN R
Citation: R. Willemze et al., A RANDOMIZED PHASE-II STUDY ON THE EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE COMBINED WITH EITHER AMSACRINE OR IDARUBICIN IN PATIENTS WITH RELAPSEDACUTE-LEUKEMIA - AN EORTC LEUKEMIA COOPERATIVE GROUP PHASE-II STUDY-(06893), Leukemia, 11, 1997, pp. 24-27
Citation: C. Debruyn et al., CELL-CYCLE STATUS OF CD34(-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER CYTOKINE STIMULATION() SUBPOPULATIONS FROM UMBILICAL), Experimental hematology, 25(8), 1997, pp. 256-256
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) B-LYMPHOCYTES BUT NOT NORMAL B-LYMPHOCYTES ARE RESCUED FROM APOPTOSIS BY CONTACT WITH BONE-MARROW STROMAL CELLS, Experimental hematology, 25(8), 1997, pp. 469-469
Authors:
ARCHIMBAUD E
MICHALLET M
PHILIP L
CHARRIN C
CLAPISSON G
BELHABRI A
GUILHOT F
STRYCKMANS P
ADELEINE P
FIERE D
Citation: E. Archimbaud et al., G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 25(8), 1997, pp. 494-494
Authors:
ZITTOUN R
SUCIU S
WATSON M
SOLBU G
MUUS P
MANDELLI F
STRYCKMANS P
PEETERMANS M
THALER J
RESEGOTTI L
DARDENNE M
WILLEMZE R
Citation: R. Zittoun et al., QUALITY-OF-LIFE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN PROLONGED FIRST COMPLETE REMISSION AFTER BONE-MARROW TRANSPLANTATION (ALLOGENEIC OR AUTOLOGOUS) OR CHEMOTHERAPY - A CROSS-SECTIONAL STUDY OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 20(4), 1997, pp. 307-315
Authors:
TRENSCHEL R
BERNIER M
STRYCKMANS P
VERHEST A
BADJOU R
CROMBEZ P
BRON D
Citation: R. Trenschel et al., COMPLETE REMISSION FOLLOWING DONOR PBSC AFTER LOW-DOSE CYTARABINE CHEMOTHERAPY FOR EARLY RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 381-383
Authors:
ARCHIMBAUD E
MICHALLET M
PHILIP I
CHARRIN C
CLAPISSON G
BELHABRI A
GUILHOT F
STRYCKMANS P
ADELEINE P
FIERE D
Citation: E. Archimbaud et al., GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 99(3), 1997, pp. 678-684
Authors:
LAGNEAUX L
DELFORGE A
BRON D
MASSY M
BERNIER M
STRYCKMANS P
Citation: L. Lagneaux et al., HETEROGENOUS RESPONSE OF B-LYMPHOCYTES TO TRANSFORMING GROWTH-FACTOR-BETA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH THE EXPRESSION OF TGF-BETA RECEPTORS, British Journal of Haematology, 97(3), 1997, pp. 612-620
Authors:
LOWENBERG B
SUCIU S
ARCHIMBAUD E
OSSENKOPPELE G
VERHOEF GEG
VELLENGA E
WIJERMANS P
BERNEMAN Z
DEKKER AW
STRYCKMANS P
SCHOUTEN H
JEHN U
MUUS P
SONNEVELD P
DARDENNE M
ZITTOUN R
Citation: B. Lowenberg et al., USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON), Blood, 90(8), 1997, pp. 2952-2961
Citation: C. Debruyn et al., CHARACTERIZATION OF CD34(-) CELLS FROM UMBILICAL-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER STIMULATION BY SCF+IL-3()CD38(+) AND OF CD34(+)CD38(), Blood, 90(10), 1997, pp. 3355-3355
Authors:
STRYCKMANS P
SUCIU S
ANNINO L
SAGLIO G
MUUS P
MARIE JP
DOMBRET H
GAMBERT J
SOLBU G
DARDENNE M
MANDELLI F
FIERE D
Citation: P. Stryckmans et al., MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC), Blood, 90(10), 1997, pp. 809-809
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
STRYCKMANS P
Citation: L. Lagneaux et al., B-CHRONIC LYMPHOCYTIC LEUKEMIC-CELLS ARE PROTECTED FROM SPONTANEOUS APOPTOSIS AFTER ADHESION TO BONE-MARROW STROMA - ROLE OF BETA-1 AND BETA-2 INTEGRINS, Blood, 90(10), 1997, pp. 2326-2326
Authors:
ZITTOUN R
SUCIU S
MANDELLI F
DEWITTE T
THALER J
STRYCKMANS P
HAYAT M
PEETERMANS M
CADIOU M
SOLBU G
PETTI MC
WILLEMZE R
Citation: R. Zittoun et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP, Journal of clinical oncology, 14(7), 1996, pp. 2150-2159
Authors:
DEBRUYN C
STRYCKMANS P
BRON D
MASSY M
BERNIER M
DEHEMPTINNE D
DELFORGE A
Citation: C. Debruyn et al., CELL-CYCLE STATUS AND KINETICS OF CD34(-BLOOD AND BONE-MARROW() SUBPOPULATIONS FROM CORD), Experimental hematology, 24(9), 1996, pp. 52-52
Authors:
LAGNEAUX L
DELFORGE A
BOSMANS E
BRUGGEMAN C
SNOECK R
STRYCKMANS P
BRON D
Citation: L. Lagneaux et al., RECOMBINANT PROTEINS OF HUMAN CYTOMEGALOVIRUS (GB, PP65, AND PP150) INCREASE CONSTITUTIVE PRODUCTION OF IL-6 AND LIF BY BONE-MARROW STROMALCELLS, Experimental hematology, 24(9), 1996, pp. 508-508
Authors:
LAGNEAUX L
DELFORGE A
BRON D
DEBRUYN C
DORVAL C
MASSY M
BERNIER M
STRYCKMANS P
Citation: L. Lagneaux et al., CHRONIC LYMPHOCYTIC LEUKEMIC (CLL) B-LYMPHOCYTES ADHERING TO BONE-MARROW STROMAL CELLS ARE PROTECTED FROM APOPTOSIS, Experimental hematology, 24(9), 1996, pp. 515-515
Citation: C. Biernaux et al., VERY-LOW LEVEL OF MAJOR BCR-ABL EXPRESSION IN BLOOD OF SOME HEALTHY-INDIVIDUALS, Bone marrow transplantation, 17, 1996, pp. 45-47